TCM Ltd

TCM Ltd, a micro-cap player in the commodity chemicals sector, has reported a significant deterioration in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to negative, with key metrics such as profit before tax, net sales, and profit after tax showing marked declines compared to previous periods. This downturn comes despite a recent uptick in the stock price, reflecting a complex market sentiment towards the company’s prospects.

TCM Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹36.00 crores, reported a consolidated net loss of ₹1.65 crores for Q4 FY26 (quarter ended March 2026), marking a 44.74% sequential deterioration from the previous quarter's loss of ₹1.14 crores. On a year-over-year basis, the company's performance collapsed by 140.94%, swinging from a ₹4.03 crore profit in Q4 FY25 to deep red ink, as revenue plummeted 35.69% to ₹4.92 crores.

TCM Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge of nearly 20% in a single day reflects renewed market interest, but underlying operational challenges remain significant.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 April 2026, providing investors with the latest insights into its performance and outlook.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with the most up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

TCM Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trend, and technical indicators. The downgrade reflects deteriorating fundamentals, subdued financial performance, and a shift in technical momentum, signalling heightened risks for investors.

TCM Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company continues to grapple with weak financial fundamentals and challenging valuation metrics.

TCM Ltd, a player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 9 March 2026. This shift reflects deteriorating fundamentals, challenging valuation metrics, and a complex technical outlook, signalling heightened risk for investors amid a volatile market environment.

TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

TCM Ltd, a player in the commodity chemicals sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of decline. Despite a modest improvement in its financial trend score, the company continues to face challenges with net sales contracting and a cautious market outlook reflected in its current Mojo Grade of Sell.

TCM Limited, the micro-cap commodity chemicals firm formerly known as Travancore Chemical & Manufacturing Company Limited, reported a consolidated net loss of ₹1.14 crores for Q3 FY26, marking the company's ninth consecutive quarterly loss. Despite a marginal improvement in losses compared to the previous quarter, the company's operational struggles continue to weigh heavily on investor sentiment, with the stock trading at ₹53.00 and commanding a market capitalisation of just ₹39.63 crores.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.